Suboptimal therapy and clinical management of gonorrhoea in an area with high-level antimicrobial resistance

Po-Lin Chen, Y. H. Hsieh, H. C. Lee, Nai-Ying Ko, Nan-Yao Lee, C. J. Wu, Chia-Ming Chang, C. C. Lee, Wen-Chien Ko

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The choice of antimicrobial agents for the treatment of gonorrhoea is critical in areas where the prevalence of drug resistance is high. This study aimed to evaluate the antibiotic treatment of gonorrhoea in endemic areas. During 1999-2004, all Neisseria gonorrhoeae infections (n = 90) were evaluated. Patients' medical records and antibiotic treatment regimens were retrospectively reviewed if their isolates were viable (n = 65). In vitro antimicrobial susceptibility of N. gonorrhoeae isolates was performed. Urethritis (89%) and pelvic inflammatory disease (42%)were the most common presentations among men (n = 53) and women (n = 12), respectively. Of 54 patients with uncomplicated N. gonorrhoeae infection, 32 of them received appropriate antibiotics, including cefuroxime (n = 20), ceftriaxone (n = 10), ciprofloxacin (n = 1) and azithromycin (n = 1) during follow-ups. Among 65 patients, 53.8% were notified to the health authority. Check-ups of other sexually transmitted diseases were carried out in only 46% of patients. Not all isolates were susceptible to penicillin, 96.9% were resistant to tetracycline and 86% were resistant to ciprofloxacin. Ceftriaxone, cefixime, spectinomycin and azithromycin were active in vitro against all isolates. In conclusion, It is crucial to develop treatment guidelines according to regional antimicrobial resistances and educational programmes to improve clinical care for genital gonococcal diseases.

Original languageEnglish
Pages (from-to)225-228
Number of pages4
JournalInternational Journal of STD and AIDS
Volume20
Issue number4
DOIs
Publication statusPublished - 2009 Apr 1

Fingerprint

Gonorrhea
Neisseria gonorrhoeae
Azithromycin
Ceftriaxone
Ciprofloxacin
Anti-Bacterial Agents
Cefixime
Spectinomycin
Cefuroxime
Pelvic Inflammatory Disease
Urethritis
Therapeutics
Sexually Transmitted Diseases
Anti-Infective Agents
Infection
Tetracycline
Drug Resistance
Penicillins
Medical Records
Guidelines

All Science Journal Classification (ASJC) codes

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

@article{22f76e2843674ccaa061de88f9077822,
title = "Suboptimal therapy and clinical management of gonorrhoea in an area with high-level antimicrobial resistance",
abstract = "The choice of antimicrobial agents for the treatment of gonorrhoea is critical in areas where the prevalence of drug resistance is high. This study aimed to evaluate the antibiotic treatment of gonorrhoea in endemic areas. During 1999-2004, all Neisseria gonorrhoeae infections (n = 90) were evaluated. Patients' medical records and antibiotic treatment regimens were retrospectively reviewed if their isolates were viable (n = 65). In vitro antimicrobial susceptibility of N. gonorrhoeae isolates was performed. Urethritis (89{\%}) and pelvic inflammatory disease (42{\%})were the most common presentations among men (n = 53) and women (n = 12), respectively. Of 54 patients with uncomplicated N. gonorrhoeae infection, 32 of them received appropriate antibiotics, including cefuroxime (n = 20), ceftriaxone (n = 10), ciprofloxacin (n = 1) and azithromycin (n = 1) during follow-ups. Among 65 patients, 53.8{\%} were notified to the health authority. Check-ups of other sexually transmitted diseases were carried out in only 46{\%} of patients. Not all isolates were susceptible to penicillin, 96.9{\%} were resistant to tetracycline and 86{\%} were resistant to ciprofloxacin. Ceftriaxone, cefixime, spectinomycin and azithromycin were active in vitro against all isolates. In conclusion, It is crucial to develop treatment guidelines according to regional antimicrobial resistances and educational programmes to improve clinical care for genital gonococcal diseases.",
author = "Po-Lin Chen and Hsieh, {Y. H.} and Lee, {H. C.} and Nai-Ying Ko and Nan-Yao Lee and Wu, {C. J.} and Chia-Ming Chang and Lee, {C. C.} and Wen-Chien Ko",
year = "2009",
month = "4",
day = "1",
doi = "10.1258/ijsa.2008.008286",
language = "English",
volume = "20",
pages = "225--228",
journal = "International Journal of STD and AIDS",
issn = "0956-4624",
publisher = "SAGE Publications Ltd",
number = "4",

}

Suboptimal therapy and clinical management of gonorrhoea in an area with high-level antimicrobial resistance. / Chen, Po-Lin; Hsieh, Y. H.; Lee, H. C.; Ko, Nai-Ying; Lee, Nan-Yao; Wu, C. J.; Chang, Chia-Ming; Lee, C. C.; Ko, Wen-Chien.

In: International Journal of STD and AIDS, Vol. 20, No. 4, 01.04.2009, p. 225-228.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Suboptimal therapy and clinical management of gonorrhoea in an area with high-level antimicrobial resistance

AU - Chen, Po-Lin

AU - Hsieh, Y. H.

AU - Lee, H. C.

AU - Ko, Nai-Ying

AU - Lee, Nan-Yao

AU - Wu, C. J.

AU - Chang, Chia-Ming

AU - Lee, C. C.

AU - Ko, Wen-Chien

PY - 2009/4/1

Y1 - 2009/4/1

N2 - The choice of antimicrobial agents for the treatment of gonorrhoea is critical in areas where the prevalence of drug resistance is high. This study aimed to evaluate the antibiotic treatment of gonorrhoea in endemic areas. During 1999-2004, all Neisseria gonorrhoeae infections (n = 90) were evaluated. Patients' medical records and antibiotic treatment regimens were retrospectively reviewed if their isolates were viable (n = 65). In vitro antimicrobial susceptibility of N. gonorrhoeae isolates was performed. Urethritis (89%) and pelvic inflammatory disease (42%)were the most common presentations among men (n = 53) and women (n = 12), respectively. Of 54 patients with uncomplicated N. gonorrhoeae infection, 32 of them received appropriate antibiotics, including cefuroxime (n = 20), ceftriaxone (n = 10), ciprofloxacin (n = 1) and azithromycin (n = 1) during follow-ups. Among 65 patients, 53.8% were notified to the health authority. Check-ups of other sexually transmitted diseases were carried out in only 46% of patients. Not all isolates were susceptible to penicillin, 96.9% were resistant to tetracycline and 86% were resistant to ciprofloxacin. Ceftriaxone, cefixime, spectinomycin and azithromycin were active in vitro against all isolates. In conclusion, It is crucial to develop treatment guidelines according to regional antimicrobial resistances and educational programmes to improve clinical care for genital gonococcal diseases.

AB - The choice of antimicrobial agents for the treatment of gonorrhoea is critical in areas where the prevalence of drug resistance is high. This study aimed to evaluate the antibiotic treatment of gonorrhoea in endemic areas. During 1999-2004, all Neisseria gonorrhoeae infections (n = 90) were evaluated. Patients' medical records and antibiotic treatment regimens were retrospectively reviewed if their isolates were viable (n = 65). In vitro antimicrobial susceptibility of N. gonorrhoeae isolates was performed. Urethritis (89%) and pelvic inflammatory disease (42%)were the most common presentations among men (n = 53) and women (n = 12), respectively. Of 54 patients with uncomplicated N. gonorrhoeae infection, 32 of them received appropriate antibiotics, including cefuroxime (n = 20), ceftriaxone (n = 10), ciprofloxacin (n = 1) and azithromycin (n = 1) during follow-ups. Among 65 patients, 53.8% were notified to the health authority. Check-ups of other sexually transmitted diseases were carried out in only 46% of patients. Not all isolates were susceptible to penicillin, 96.9% were resistant to tetracycline and 86% were resistant to ciprofloxacin. Ceftriaxone, cefixime, spectinomycin and azithromycin were active in vitro against all isolates. In conclusion, It is crucial to develop treatment guidelines according to regional antimicrobial resistances and educational programmes to improve clinical care for genital gonococcal diseases.

UR - http://www.scopus.com/inward/record.url?scp=66349093807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66349093807&partnerID=8YFLogxK

U2 - 10.1258/ijsa.2008.008286

DO - 10.1258/ijsa.2008.008286

M3 - Article

C2 - 19304963

AN - SCOPUS:66349093807

VL - 20

SP - 225

EP - 228

JO - International Journal of STD and AIDS

JF - International Journal of STD and AIDS

SN - 0956-4624

IS - 4

ER -